🇩🇪 Germany Country × Condition
stroke Clinical Trials in Germany
Active clinical trials for stroke with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇩🇪 Germany
Active Trials in Germany (5)
NCT03240965
Recruiting
Changes in Sensitivity, Taste and Smell in Stroke Patients
Enrollment
200 pts
Country
🇩🇪 Germany
University of Giessen
View Trial → NCT04994756
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Enrollment
40,000 pts
Country
🇩🇪 Germany
Medical University of South Carolin...
View Trial → NCT05930145
Recruiting
Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke
Enrollment
200 pts
Country
🇩🇪 Germany
Fundación EPIC
View Trial → NCT05132517
Recruiting
Magnesium and Cognition After Stroke
Enrollment
80 pts
Country
🇩🇪 Germany
BDH-Klinik Hessisch Oldendorf
View Trial → NCT07299994
Recruiting
Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease
Enrollment
462 pts
Country
🇩🇪 Germany
Sigmund Freud PrivatUniversitat
View Trial → Frequently Asked Questions
How many stroke clinical trials are active in Germany?
There are currently 5 active clinical trials for stroke with sites in Germany, of which 5 are actively recruiting patients.
How can I join a stroke clinical trial in Germany?
To join a stroke clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are stroke trials in Germany?
Active stroke trials in Germany span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology